American Association for Cancer Research

SHERPA: Unknown

People

  1. Rosen
    Rosen
  2. Solit
    Solit
  3. Chandarlapaty
    Chandarlapaty
  4. Scher
    Scher
  5. De Stanchina
    De Stanchina
  6. Berger
    Berger
  7. Yaeger
    Yaeger
  8. Norton
    Norton
  9. Chiosis
    Chiosis
  10. Modi
    Modi

Groups

  1. Breast Medicine Service (142)
  2. Department of Medicine (142)
  3. GSK Faculty (142)
  4. Molecular Pharmacology and Chemistry Program Faculty (142)
  5. Sloan Kettering Institute Faculty (142)
  6. Solid Tumor Oncology Division (142)
  7. Human Oncology and Pathogenesis Program (101)
  8. Genitourinary Oncology Service (72)
  9. Sloan Kettering Institute Postdocs (49)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (46)
Search Within
  1. "Neal Rosen"
Formats
  1. Meeting Abstract (94)
  2. Journal Article (48)
Groups
  1. Breast Medicine Service (142)
  2. Department of Medicine (142)
  3. GSK Faculty (142)
  4. Molecular Pharmacology and Chemistry Program Faculty (142)
  5. Sloan Kettering Institute Faculty (142)
  6. Solid Tumor Oncology Division (142)

More Groups

People
  1. Neal Rosen (142)
  2. David Solit (65)
  3. Sarat Chandarlapaty (29)
  4. Christine Pratilas (22)
  5. Andrea Basso (16)
  6. Qing-Bai She (16)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2022 (4)
  4. 2021 (3)
  5. 2020 (6)
  6. 2019 (3)

More Years

Publications
  1. Cancer Research (99)
  2. Clinical Cancer Research (43)

Results (142)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration
    Journal Article

    Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reversibility of tumor adaptations to PI3K inhibition decreases as a function of time
    Meeting Abstract

    Mukherjee, R.; de Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • KRAS(G12C) mutation is associated with increased risk of recurrence in surgically resected lung adenocarcinoma
    Journal Article

    Jones, G. D.; Caso, R.; Tan, K. S.; Mastrogiacomo, B.; Sanchez-Vega, F.; Liu, Y.; Connolly, J. G.; Murciano-Goroff, Y. R.; Bott, M. J.; Adusumilli, P. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors
    Meeting Abstract

    Yuan, X.; Zhang, X.; Du, R.; Cheung, S. H.; Wei, M.; Zhou, C.; Wang, L.; Shearer, T.; Edris, B.; Smith, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: